|
|||||
|
|
Atomoxetine: A Selective Norepinephrine Reuptake Inhibitor for the Treatment of Attention-Deficit/Hyperactivity Disorder. |
|
| Authors: | Rivas-Vazquez Rafael A. |
| Abstract: | This column offers data related to attention deficit disorder with hyperactivity and related psychopharmacological treatments. The author focuses on atomoxetime, a selective norepinephrine reuptake inhibitor, and offers efficacy and safety data. Conclusions point out the limitations of stimulant use and praise the alleged non-abusive nature of atomoxetine. (PsycINFO Database Record (c) 2010 APA, all rights reserved) |
| Keywords: | attention deficit disorder hyperactivity pharmacological treatment drug therapy atomoxetime |